Velocity Clinical Research:  The Value-Added Site Organization Designed to Raise the Research Bar

clinical research

Velocity Clinical Research recently announced important additions to its senior leadership team including: Jeffrey Jensen, Senior Vice President, Operations; Jamie Wilkerson, Vice President, Finance and Craig M. Koch, Vice President, Business Development.  They join president and Chief Executive Officer Paul Evans and Executive Chairman Bruce Tomason in setting a new standard of rapid data delivery in clinical trials matched with the highest level of patient care. These executive additions represent an incredibly well-rounded, deeply experience, savvy group.

Velocity Clinical Research (Velocity) represents a potential advancement in how clinical research is conducted.  The venture was founded to address fundamental gaps in the clinical trials research market ecosystem. Patient recruitment and data delivery timelines are arguably the weakest link in the sector, with over 50% delays in drug development occurring at the site level.  Velocity Clinical Research is poised to delivery substantial growth in 2019 while maintaining already excellent quality standards.  Velocity’s growth will allow it to serve more customers and enhance its ability to break through conventional industry-st...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee